Preclinical and Clinical Evidence Supporting Use of Cannabidiol in Psychiatry

BACKGROUND: Cannabidiol (CBD) is a major chemical compound present in Cannabis sativa. CBD is a nonpsychotomimetic substance, and it is considered one of the most promising candidates for the treatment of psychiatric disorders. OBJECTIVE: The aim of this review is to illustrate the state of art abou...

Descripción completa

Detalles Bibliográficos
Autores principales: Calapai, Gioacchino, Mannucci, Carmen, Chinou, Ioanna, Cardia, Luigi, Calapai, Fabrizio, Sorbara, Emanuela Elisa, Firenzuoli, Bernardo, Ricca, Valdo, Gensini, Gian Franco, Firenzuoli, Fabio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6735178/
https://www.ncbi.nlm.nih.gov/pubmed/31558911
http://dx.doi.org/10.1155/2019/2509129

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6735178/
https://www.ncbi.nlm.nih.gov/pubmed/31558911
http://dx.doi.org/10.1155/2019/2509129

Ejemplares similares